These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28569211)

  • 1. Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis.
    Yoo J; Lee SK; Lim M; Sheen D; Choi EH; Kim SA
    Arthritis Res Ther; 2017 May; 19(1):119. PubMed ID: 28569211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expressions and potential clinical values of lncRNAs in the plasma exosomes of rheumatoid arthritis.
    Shuai ZQ; Wang ZX; Ren JL; Yang XK; Xu B
    Int Immunopharmacol; 2024 Feb; 128():111511. PubMed ID: 38194746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis.
    Shen C; Sun XG; Liu N; Mu Y; Hong CC; Wei W; Zheng F
    Mol Med Rep; 2015 Feb; 11(2):1528-34. PubMed ID: 25352049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker.
    Hwang YG; Balasubramani GK; Metes ID; Levesque MC; Bridges SL; Moreland LW
    Arthritis Res Ther; 2016 May; 18(1):108. PubMed ID: 27188329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Exosomal miRNA-1915-3p Is Correlated With Disease Activity of Korean Rheumatoid Arthritis.
    Lim MK; Yoo J; Sheen DH; Ihm C; Lee SK; Kim SA
    In Vivo; 2020; 34(5):2941-2945. PubMed ID: 32871836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
    Connolly M; Mullan RH; McCormick J; Matthews C; Sullivan O; Kennedy A; FitzGerald O; Poole AR; Bresnihan B; Veale DJ; Fearon U
    Arthritis Rheum; 2012 Apr; 64(4):1035-45. PubMed ID: 22076945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
    Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
    Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
    Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid A in the assessment of early inflammatory arthritis.
    Cunnane G; Grehan S; Geoghegan S; McCormack C; Shields D; Whitehead AS; Bresnihan B; Fitzgerald O
    J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction-Measurement by ELISA.
    Yokoyama S; Takeuchi A; Yamaguchi S; Mitani Y; Watanabe T; Matsuda K; Hotta T; Shively JE; Yamaue H
    PLoS One; 2017; 12(8):e0183337. PubMed ID: 28817685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.
    Hur B; Gupta VK; Huang H; Wright KA; Warrington KJ; Taneja V; Davis JM; Sung J
    Arthritis Res Ther; 2021 Jun; 23(1):164. PubMed ID: 34103083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab.
    Hirata S; Marotta A; Gui Y; Hanami K; Tanaka Y
    Arthritis Res Ther; 2015 Oct; 17():280. PubMed ID: 26449724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Proteomic Analysis Reveals Distinct Exosomal Protein Profiles in Rheumatoid Arthritis.
    Qin Q; Song R; Du P; Gao C; Yao Q; Zhang JA
    J Immunol Res; 2021; 2021():9421720. PubMed ID: 34458379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis.
    Kane D; Roth J; Frosch M; Vogl T; Bresnihan B; FitzGerald O
    Arthritis Rheum; 2003 Jun; 48(6):1676-85. PubMed ID: 12794836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
    Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Yamamura Y; Tomoda K; Tsukano M; Shono M; Baba S
    Clin Rheumatol; 2003 Dec; 22(6):371-5. PubMed ID: 14677008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum level of reactive oxygen metabolites (ROM) at 12 weeks of treatment with biologic agents for rheumatoid arthritis is a novel predictor for 52-week remission.
    Nakajima A; Aoki Y; Sonobe M; Takahashi H; Saito M; Nakagawa K
    Clin Rheumatol; 2017 Feb; 36(2):309-315. PubMed ID: 27858176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation study between interleukin-17 and ESR and CRP in serum and the synovial fluid of rheumatoid arthritis patients of accumulated dampness-heat obstruction in joints syndrome].
    Liu DF; Yan J; Guo MY; Wang C; Hu YH; Yang M; Yun MD; Luo Y; Zhang J; Li H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar; 34(3):272-5. PubMed ID: 24758074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission.
    Toldi G; Bekő G; Kádár G; Mácsai E; Kovács L; Vásárhelyi B; Balog A
    Clin Chem Lab Med; 2013 Feb; 51(2):327-32. PubMed ID: 22718576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen and nitrogen species in patients with rheumatoid arthritis as potential biomarkers for disease activity and the role of antioxidants.
    Khojah HM; Ahmed S; Abdel-Rahman MS; Hamza AB
    Free Radic Biol Med; 2016 Aug; 97():285-291. PubMed ID: 27344969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.